Indoco Remedies (BOM:532612) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532612 Indoco Remedies Ltd BOM:532612
64 GF Score
Price ₹231.20
GF Value ₹345.62
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Indoco Remedies FFO per Share?

FFO per Share only applies to REITs.

BOM:532612
64GF Score
Indoco Remedies Ltd BOM:532612
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Indoco Remedies (BOM:532612) Overvalued in 2026?

Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued. The current stock price of ₹231.20 is trading 33.1% below its estimated GF Value™ of ₹345.62. GuruFocus considers Indoco Remedies to be Modestly Undervalued.

Key valuation signals for BOM:532612:

  • FFO per Share:
  • GF Value™: ₹345.62 vs. price of ₹231.20 (33.1% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the BOM:532612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indoco Remedies Business Description

Other Exchanges INDOCO:India
Address 166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
64GF Score

Get the complete analysis for BOM:532612

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹231.20
Price
₹345.62
GF Value